Chapter

HPV vaccination in the developing world

Rengaswamy Sankaranarayanan and Catherine Sauvaget

in Vaccines for the Prevention of Cervical Cancer

Published on behalf of Oxford University Press

ISBN: 9780199543458
Published online May 2011 | e-ISBN: 9780199607181 | DOI: http://dx.doi.org/10.1093/med/9780199543458.003.0010

Series: Oxford Oncology Library

HPV vaccination in the developing world

Show Summary Details

Preview

• Four-fifths of the cervical cancer burden is in the developing world where there is a lack of effective screening. • The potential to reduce cervical cancer by human papilloma virus (HPV) vaccination in developing countries is challenged by cost and lack of effective vaccine delivery platforms for children and adolescents. • Other challenges include the following: • Sensitivities of using a vaccine preventing an STI in girls • Lack of awareness, public demand, and political will • Lack of coordination between cancer control, sexual/reproductive health, and vaccine delivery services. • Local production of vaccines at reduced cost, logistically feasible efficacious vaccine regimes, and strengthening vaccine delivery infrastructure for children and adolescents will be required for successful HPV vaccination in developing countries. •

Chapter.  3119 words.  Illustrated.

Subjects: Medical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.